Source: EIN Presswire

Press Release: Vidac Pharma : European Commission Selects Vidac Pharma's Tuvatexib Project for STEP Seal under EIC Accelerator

Vidac Pharma's Tuvatexib project earns STEP Seal under Horizon Europe, recognizing its innovation in treating precancerous skin lesions. Vidac Pharma PLC (XSTU:T9G; ISIN: GB00BM9XQ619; WKN: A3DTUQ) LONDON, UNITED KINGDOM, June 17, 2025 /⁨EINPresswire. ...

Read full article »
Vidac Pharma's Competitors | Vidac Pharma's News | Vidac Pharma's Financials
Stay up-to-date with the latest news on Vidac Pharma
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Oren M. Becker's photo - President & CEO of Vidac Pharma

President & CEO

Oren M. Becker

CEO Approval Rating

69/100

Read more
Stay up-to-date with the latest news on Vidac Pharma